Boston Business Journal featured LexaGene in a story about how the company is trying to tackle possible under-reporting of EEE virus.
Boston Business Journal article
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
October 05, 2021 - October 06, 2021
The in-person and virtual event held in New York City attracted more than 550 attendees, including 100 speakers sharing their expertise, insight, and predictions.
Sorry, we don't have any content in this category with that format. Is there anything we can help you with?